Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 16, 2017
Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis
Jun Teishima, Shinya Ohara, Kousuke Sadahide, et al.
Histopathology
|
October 22, 2011
Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma
Tetsutaro Hayashi, Kazuhiro Sentani, Naohide Oue, et al.
International Journal of Cancer
|
August 12, 2009
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients
Naohide Oue, Kazuhiro Sentani, Tsuyoshi Noguchi, et al.
Japanese Journal of Clinical Oncology
|
April 27, 2013
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report
Shigeyuki Yamada, Hideo Saito, Shinya Ohara, et al.
Frontiers in Neural Circuits
|
December 24, 2021
Laminar Organization of the Entorhinal Cortex in Macaque Monkeys Based on Cell-Type-Specific Markers and Connectivity
Shinya Ohara, Rintaro Yoshino, Kei Kimura, et al.
BJU International
|
August 26, 2015
The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma
Jun Teishima, Kohei Kobatake, Hiroyuki Kitano, et al.
Oncology Letters
|
July 12, 2014
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy
Jun Teishima, Kohei Kobatake, Tetsutaro Hayashi, et al.
Urologic Oncology
|
August 6, 2017
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
Jun Teishima, Kohei Kobatake, Shunsuke Shinmei, et al.
BJU International
|
August 18, 2020
Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification
Yuki Kohada, Tetsutaro Hayashi, Ryan S Hsi, et al.
Hiroshima Journal of Medical Sciences
|
November 8, 2011
Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer
Jun Teishima, Masahiro Kenjo, Kohei Kobatake, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 16, 2017
Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis
Jun Teishima, Shinya Ohara, Kousuke Sadahide, et al.
Histopathology
|
October 22, 2011
Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma
Tetsutaro Hayashi, Kazuhiro Sentani, Naohide Oue, et al.
International Journal of Cancer
|
August 12, 2009
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients
Naohide Oue, Kazuhiro Sentani, Tsuyoshi Noguchi, et al.
Japanese Journal of Clinical Oncology
|
April 27, 2013
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report
Shigeyuki Yamada, Hideo Saito, Shinya Ohara, et al.
Frontiers in Neural Circuits
|
December 24, 2021
Laminar Organization of the Entorhinal Cortex in Macaque Monkeys Based on Cell-Type-Specific Markers and Connectivity
Shinya Ohara, Rintaro Yoshino, Kei Kimura, et al.
BJU International
|
August 26, 2015
The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma
Jun Teishima, Kohei Kobatake, Hiroyuki Kitano, et al.
Oncology Letters
|
July 12, 2014
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy
Jun Teishima, Kohei Kobatake, Tetsutaro Hayashi, et al.
Urologic Oncology
|
August 6, 2017
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
Jun Teishima, Kohei Kobatake, Shunsuke Shinmei, et al.
BJU International
|
August 18, 2020
Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification
Yuki Kohada, Tetsutaro Hayashi, Ryan S Hsi, et al.
Hiroshima Journal of Medical Sciences
|
November 8, 2011
Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer
Jun Teishima, Masahiro Kenjo, Kohei Kobatake, et al.
Page
of 7